Cancer Treatment Research in New York
Cancer Treatment Research (93.395) awarded $604 million to recipients in New York in 347 grants from fiscal 2021 to 2025, 11% of the program's national total. Icahn School of Medicine at Mount Sinai received the most, $179 million.
- Awarded in New York$604 million
- Awards347
- Share of the program11%
- Rank among states2nd of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 157 | $104 million |
| FY 2022 | 163 | $112 million |
| FY 2023 | 184 | $124 million |
| FY 2024 | 194 | $128 million |
| FY 2025 | 195 | $136 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | Colleges and universities | 35 | $179 million |
| Sloan-Kettering Institute for Cancer Research | Nonprofits | 75 | $133 million |
| New York University | Colleges and universities | 34 | $44.9 million |
| Weill Medical College of Cornell University | Colleges and universities | 34 | $44.6 million |
| Health Research, Inc. | Nonprofits | 27 | $43.1 million |
| Albert Einstein College of Medicine | Colleges and universities | 16 | $22.5 million |
| The Trustees of Columbia University in the City of New York | Colleges and universities | 24 | $20.5 million |
| The Research Foundation for the State University of New York | Other | 14 | $18.0 million |
| University of Rochester | Colleges and universities | 18 | $17.8 million |
| The Research Foundation for the State University of New York | Nonprofits | 11 | $16.1 million |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to New York?
$604 million from fiscal 2021 to 2025, across 347 awards. New York ranks 2nd of 50 states and territories for this program.
Who receives Cancer Treatment Research money in New York?
The largest recipient is Icahn School of Medicine at Mount Sinai, with $179 million in 35 awards. Next are Sloan-Kettering Institute for Cancer Research and New York University.
Can organizations in New York apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund